Kalbe Farma Tbk PT Cash Flow Conversion Efficiency

Latest as of June 2026: 0.041x

Kalbe Farma Tbk PT cash flow conversion efficiency. Based on the latest financial reports, Kalbe Farma Tbk PT (KLBF) has a cash flow conversion efficiency ratio of 0.041x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp1.05 Trillion ≈ $61.81 Million USD) by net assets (Rp25.76 Trillion ≈ $1.51 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Kalbe Farma Tbk PT (2000–2025)

Cash flow conversion efficiency of Kalbe Farma Tbk PT from 2000 to 2025. This chart illustrates how Kalbe Farma Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. View KLBF stock price for real-time trading data and today's change.

Kalbe Farma Tbk PT Cash Flow Conversion Ratio Explained

Kalbe Farma Tbk PT cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Kalbe Farma Tbk PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kalbe Farma Tbk PT ranked by their cash flow conversion efficiency. Also see KLBF company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
EIH Limited
NSE:EIHOTEL
0.054x
Xinxing Ductile Iron Pipes Co Ltd
SHE:000778
-0.010x
China Meheco Co Ltd
SHG:600056
0.016x
FAIRFAX INDIA HLDGS
F:F5X
0.007x
Cosmo Electronics Corp
TW:2466
-0.020x
VGP NV
BR:VGP
-0.006x
Guangxi Guitang Group Co Ltd
SHE:000833
0.058x
Anhui Heli Co Ltd
SHG:600761
0.035x

Annual Cash Flow Conversion Efficiency for Kalbe Farma Tbk PT (2000–2025)

The table below shows the annual cash flow conversion efficiency of Kalbe Farma Tbk PT from 2000 to 2025. Review KLBF free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Rp24.73 Trillion
≈ $1.45 Billion
Rp3.27 Trillion
≈ $191.65 Million
0.132x -32.03%
2024-12-31 Rp24.59 Trillion
≈ $1.44 Billion
Rp4.79 Trillion
≈ $280.39 Million
0.195x +54.74%
2023-12-31 Rp23.12 Trillion
≈ $1.35 Billion
Rp2.91 Trillion
≈ $170.37 Million
0.126x -26.28%
2022-12-31 Rp22.10 Trillion
≈ $1.29 Billion
Rp3.77 Trillion
≈ $220.87 Million
0.171x +28.37%
2021-12-31 Rp21.27 Trillion
≈ $1.25 Billion
Rp2.83 Trillion
≈ $165.59 Million
0.133x -42.38%
2020-12-31 Rp18.28 Trillion
≈ $1.07 Billion
Rp4.21 Trillion
≈ $246.97 Million
0.231x +53.92%
2019-12-31 Rp16.71 Trillion
≈ $978.88 Million
Rp2.50 Trillion
≈ $146.66 Million
0.150x -17.30%
2018-12-31 Rp15.29 Trillion
≈ $896.20 Million
Rp2.77 Trillion
≈ $162.36 Million
0.181x +25.33%
2017-12-31 Rp13.89 Trillion
≈ $814.14 Million
Rp2.01 Trillion
≈ $117.68 Million
0.145x -16.59%
2016-12-31 Rp12.46 Trillion
≈ $730.33 Million
Rp2.16 Trillion
≈ $126.56 Million
0.173x -22.85%
2015-12-31 Rp10.94 Trillion
≈ $640.94 Million
Rp2.46 Trillion
≈ $143.97 Million
0.225x -4.79%
2014-12-31 Rp9.82 Trillion
≈ $575.27 Million
Rp2.32 Trillion
≈ $135.72 Million
0.236x +116.28%
2013-12-31 Rp8.50 Trillion
≈ $498.06 Million
Rp927.16 Billion
≈ $54.33 Million
0.109x -41.58%
2012-12-31 Rp7.37 Trillion
≈ $431.95 Million
Rp1.38 Trillion
≈ $80.65 Million
0.187x -17.44%
2011-12-31 Rp6.52 Trillion
≈ $381.81 Million
Rp1.47 Trillion
≈ $86.34 Million
0.226x +13.15%
2010-12-31 Rp5.77 Trillion
≈ $338.21 Million
Rp1.15 Trillion
≈ $67.60 Million
0.200x -29.78%
2009-12-31 Rp4.79 Trillion
≈ $280.71 Million
Rp1.36 Trillion
≈ $79.90 Million
0.285x +53.10%
2008-12-31 Rp4.34 Trillion
≈ $254.57 Million
Rp807.70 Billion
≈ $47.33 Million
0.186x +105.77%
2007-12-31 Rp4.02 Trillion
≈ $235.36 Million
Rp362.90 Billion
≈ $21.26 Million
0.090x -50.02%
2006-12-31 Rp3.54 Trillion
≈ $207.67 Million
Rp640.61 Billion
≈ $37.54 Million
0.181x +15.14%
2005-12-31 Rp2.81 Trillion
≈ $164.74 Million
Rp441.37 Billion
≈ $25.86 Million
0.157x -45.36%
2004-12-31 Rp1.48 Trillion
≈ $86.69 Million
Rp425.07 Billion
≈ $24.91 Million
0.287x -42.02%
2003-12-31 Rp1.02 Trillion
≈ $59.97 Million
Rp507.17 Billion
≈ $29.72 Million
0.496x -19.13%
2002-12-31 Rp651.41 Billion
≈ $38.17 Million
Rp399.13 Billion
≈ $23.39 Million
0.613x +25.47%
2001-12-31 Rp345.97 Billion
≈ $20.27 Million
Rp168.95 Billion
≈ $9.90 Million
0.488x +52.08%
2000-12-31 Rp305.74 Billion
≈ $17.91 Million
Rp98.17 Billion
≈ $5.75 Million
0.321x --

About Kalbe Farma Tbk PT

JK:KLBF Indonesia Drug Manufacturers - General
Market Cap
$1.94 Billion
Rp33.03 Trillion IDR
Market Cap Rank
#6030 Global
#45 in Indonesia
Share Price
Rp730.00
Change (1 day)
+2.10%
52-Week Range
Rp655.00 - Rp1320.00
All Time High
Rp2271.54
About

PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devi… Read more